Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
10/2008
10/14/2008US7436570 Electrochromic salts, solutions, and devices
10/14/2008US7435831 Bicyclic and bridged nitrogen heterocycles
10/14/2008US7435830 Bicyclic and bridged nitrogen heterocycles
10/14/2008US7435823 2,3-Dihydro-4H-1,4-benzoxazine derivatives containing an optionally fused pyridine or pyrimidine ring; 7-((6,7-bis(methyloxy)-4-quinolinyl)oxy)-N-phenyl-2,3-dihydro-4H-1,4-benzoxazine-4-carboxamide; kinase inhibitors; inflammation, angiogenesis and cancer
10/14/2008US7435750 Method of using substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
10/14/2008US7435742 potent antagonists of M3 muscarinic receptors; chronic obstructive pulmonary disease; bronchitis, bronchial hyperreactivity, asthma, cough and rhinitis; gastrointestinal disorders; incontinenc; [2-(3,4-Dimethoxyphenyl)ethyl]-(5-methylfuran-2-ylmethyl)carbamic acid (3R)-1 -azabicyclo[2.2.2]oct-3-yl ester
10/14/2008US7435740 e.g. 1-Benzyl-7-phenyl-3-propyl-1H-pyrrolo[1,2-f]purine-2,4(3H,6H)-dione; antiinflammatory, anticarcinogenic agent; cerebral ischemia, asthma, neurodegeneration, glaucoma, ischemic heart pre-conditioning; diagnostic agents
10/14/2008US7435739 Antiproliferative agents; skin, prostate glands, kidneys, central nervous system
10/14/2008US7435735 Hydroxy pyridopyrrolopyrazine dione compounds useful as HIV integrase inhibitors
10/14/2008US7435731 Substituted pyrazolo[3,4-d]pyrimadines and methods of using the same
10/14/2008US7435730 Short-acting benzodiazepines
10/14/2008CA2382880C N-cyclopentyl modulators of chemokine receptor activity
10/14/2008CA2309328C Cyclic amine derivatives and their use as drugs
10/09/2008WO2008121748A2 Adenosine a2a receptor antagonists
10/09/2008WO2008121261A2 Prodrugs of triciribin suitable for treatment of tumors and cancer
10/09/2008WO2008120766A1 Analgesic composition
10/09/2008WO2008120725A1 Novel pyrrolinone derivative and medicinal composition containing the same
10/09/2008WO2008119792A1 Pyrrolopyrimidine derivatives as jak3 inhibitors
10/09/2008WO2008119754A1 Processes for making zilpaterol and salts thereof
10/09/2008WO2008119713A1 1- (1-cyclohexyl-4-piperidinyl) -1, 3-dihydro-2h-benzimidazol-2-one derivatives which have activity on the m1 receptor and their use in medicine
10/09/2008WO2008119688A1 Photoactivable nitrogen bases
10/09/2008WO2008079521A3 Tricyclic heteroaryl compounds useful as inhibitors of janus kinase
10/09/2008WO2008065444B1 Substituted quinazolines
10/09/2008WO2008057873A3 Inhibitors of hepatitis c virus
10/09/2008WO2008057871A3 Inhibitors of hepatitis c virus
10/09/2008WO2008057252A3 Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and use therewith
10/09/2008WO2008049105A3 Sulfamoyl-containing derivatives and uses thereof
10/09/2008WO2007018660A3 Gabaergic imidazobenzodiazepine derivatives to treat memory deficits
10/09/2008US20080249305 imidazopyrazine compounds such as 4-{4-[2-(2,4-Difluorophenyl)-8-methylimidazo[1,2-a]pyrazin-3-yl]-pyrimidin-2-ylamino}-2-methyl-butan-2-ol, useful as kinase inhibitors, for treating inflammatory diseases and proliferative disorders
10/09/2008US20080249154 Preventive and/or Therapeutic Agent For Disease In Which Mitochondrial Benzodiazephine Receptor Participates
10/09/2008US20080249113 Fungicidal Mixtures
10/09/2008US20080249100 N-[2-(2-{[(3,4-dichlorophenyl)methyl]amino}-7-oxo-8-hydropteridin-8-yl)ethyl]carboxamides; antidiabetic, anticholesterol, anticarcinogenic, antiischemic, hypotensive agents; obesity, stroke
10/09/2008US20080249098 peripheral benzodiazepine receptors; 7-fluoro-N,N,5-trimethyl-4-oxo-3-(pyridin-2-yl)-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-carboxamide; for the treatment of various types of peripheral neuropathies, amyotrophic lateral sclerosis
10/09/2008US20080248952 Substituted 6-Phenyl-7-Aminotriazolopyrimidines, Method for the Production Thereof, Their Use for Controlling Pathogenic Fungi, and Agents Containing These Compounds
10/09/2008CA2682646A1 Pyrrolopyrimidine derivatives as jak3 inhibitors
10/09/2008CA2682473A1 Novel pyrrolinone derivative and pharmaceutical composition comprising the same
10/09/2008CA2681201A1 Photoactivable nitrogen bases
10/09/2008CA2679991A1 Processes for making zilpaterol and salts thereof
10/08/2008EP1978019A1 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
10/08/2008EP1976853A1 Novel compounds and use thereof
10/08/2008EP1976836A2 Nitrogen-containing bicyclic heteroaryl compounds for the treatment of raf protein kinase-mediated diseases
10/08/2008EP1976828A1 Diamine derivatives as inhibitors of leukotriene a4 hydrolase
10/08/2008EP1922135A4 Hindered cyclic polyamines and their salts for acid gas scrubbing process
10/08/2008EP1641799B8 Imidazo-pyridazinone derivatives and imidazo-pyridone derivatives, production thereof, and use thereof as medicaments
10/08/2008EP1633348B1 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B sb 1 /sb RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES
10/08/2008EP1606283B1 P38 inhibitors and methods of use thereof
10/08/2008EP1572694B1 Pyrrolo[2,1-c][1,4] benzodiazepines as vasopressin agonists
10/08/2008EP1485390B1 Bicyclic pyridine and pyrimidine p38 kinase inhibitors
10/08/2008EP1469000B1 Novel crystalline tricyclic triazolobenzazepine derivative
10/08/2008EP1389100B1 Novel methods for the treatment and prevention of pain using stress-activated protein kinase inhibitors
10/08/2008CN101282978A Macrocylic inhibitors of hepatitis c virus
10/08/2008CN101282930A Fab I inhibitor and process for preparing same
10/08/2008CN101279989A Preparation of high-photoelectric transformation efficiency manganese phthalocyanine bisphenol-A epoxy derivates
10/08/2008CN101279975A 荧光二酮吡咯并吡咯 Fluorescent diketopyrrolopyrrole
10/08/2008CN101279974A Pyrazolopyrimidinone derivatives, preparation and application thereof
10/08/2008CN100424084C (Zinc) porphyrin - perylene diimide ( PDI) - C60 ternary system and its synthesis method
10/07/2008US7432379 3-Amido-5-substituted pyrazole derivatives and related compounds useful as bradykinin B1 receptor antagonists to relieve adverse symptoms in mammals mediated, at least in part, by bradykinin B1 receptor including pain, inflammation, septic shock, scarring process
10/07/2008US7432373 Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors
10/07/2008US7432370 Mixing a racemic mixture of enantiomers of pyrrolo[2,3-d]pyrimidine compounds in a solvent, with a resolving compound having a defined stereospecificity, to form a solution and with resolving agent being capable of binding with enantiomers to form a precipitate collecting precipitate and purifying
10/07/2008US7432369 Pyridyl-substituted porphyrin compounds and methods of use thereof
10/07/2008US7432283 Heterocyclic GABAA subtype selective receptor modulators
10/07/2008US7432273 cancer and/or viral infection, leukemia; improved pharmacological properties; oral bioavailability, greater potency, extended half-life in vivo, Side effects reduction; 2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-6-diethoxy-phosphoryl)-hexanoic acid, diethyl cyano phosphonate
10/07/2008US7432267 imidazo(1,5-a)-pyrazine-1,3-dione derivatives; Anticancer agents; immune disorders; (5S,8S,8aR)-4-[Octahydro-7-[(1,1-dimethylethoxy)carbonyl]-1,3-dioxo-5,8-methanoimidazo[1,5-a]pyrazin-2-yl]-2-(trifluoromethyl)benzonitrile
10/07/2008US7432266 Phosphodiesterase 4 inhibitors
10/07/2008US7432265 Imidazopyrazines as cyclin dependent kinase inhibitors
10/07/2008US7432262 Use of these dipeptidylpeptidase-IV inhibitors; treating type I and II diabetes mellitus, arthritis, obesity, allograft transplantation, or calcitonin-induced osteoporosis; 2-amino-imidazo[4,5-d]pyridazine-4,7-diones
10/07/2008US7432256 Substitued imidazo [1,5-A][1,2,4]triazolo[1,5-D][1,4]benzodiazepine derivatives
10/07/2008US7431762 Wet milling dichlorodiketopyrrolopyrrole pigment wherein an alpha modification and a beta modification coexist in the presence of a milling agent and a wetting agent; viscosity; color filter material to be used in a color liquid crystal display device or a solid photographing element
10/07/2008CA2531578C A new process for preparation of imipenem
10/07/2008CA2410232C Farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer
10/07/2008CA2248143C Process to prepare oxazolidinones
10/04/2008WO2008127226A2 P13 kinase antagonists
10/04/2008CA2639579A1 Pi3 kinase antagonists
10/02/2008WO2008118468A1 Heterocyclic compounds and their uses
10/02/2008WO2008118454A2 Derivatives of quinoline or benzopyrazine and their uses for the treatment of (inter alia) inflammatory diseases, autoimmune diseases or various kinds of cancer
10/02/2008WO2008118327A1 Conformationally restrained epothilone analogues as anti-leukemic agents
10/02/2008WO2008118122A2 Compounds and amyloid probes thereof for therapeutic and imaging uses
10/02/2008WO2008117943A1 7-(3',4'-dialkoxyphenyl)-[1,2,4]-triazolo[1,5-a]pyrimidine compounds, process for preparing thereof, and pharmaceutical composition for treating or preventing asthma, chronic obstructive pulmonary disease, arthritis, atopic dermatitis, tumor and degenerative brain diseases comprising the same
10/02/2008WO2008117871A1 Nitrogen-containing redox catalyst
10/02/2008WO2008117796A1 Novel mutilin derivatives
10/02/2008WO2008117225A2 New imidazolo-heteroaryl derivatives with antibacterial properties
10/02/2008WO2008117169A1 Pyrimido [4, 5-d] azepine derivatives as 5-ht2c agonists
10/02/2008WO2008117047A1 Pyrazolo[3, 4-d]pyrimidine derivatives as antibacterial compounds
10/02/2008WO2008117046A1 Pyrazolo [4, 3-d] pyrimidines as antibacterial compounds
10/02/2008WO2008116898A1 Pyrazolo [1,5-a]pyrimidines as inhibitors of stearoyl-coa desaturase
10/02/2008WO2008116742A1 Aza-pyridopyrimidinone derivatives
10/02/2008WO2008082490A3 Novel jnk inhibitors
10/02/2008WO2008075068A3 Acylaminopyrazoles as fgfr inhibitors
10/02/2008WO2008020211A3 Benzimidazole, benzoxazole and benzothiazole derivatives, optical film comprising them and method of production thereof
10/02/2008WO2007133562A3 Monocyclic heteroaryl compounds
10/02/2008WO2007044893A3 Compounds and methods for inhibiting hepatitis c viral replication
10/02/2008US20080242870 Fluorescent aromatic sensors and their methods of use
10/02/2008US20080242860 Silver halide color photographic light-sensitive material and image formation method using the same, silver halide emulsion, reducing compound having group adsorptive to silver halide and method for producing the same
10/02/2008US20080242857 Coupling (2-iodo-3-methyl-5-pyrrolyl)(2-iodo-4-methyl-5-pyrrolyl)methane or derivative with bis(2-formyl-3-methyl-4-(2-alkoxycarbonylethyl)4-pyrrolyl)methane in an acidic medium with optiona hydrolsis or saponification; preparing heme, hemin or hematin
10/02/2008US20080242685 Chemical Compounds
10/02/2008US20080242673 novel triazolopyrimidine derivatives like 7-(2-(4-(2,5-Difluorophenyl)piperazin-1-yl)ethyl)-2-(furan-2-yl)-7H-pyrrolo[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine; to treat central nervous system disorders like depression, Parkinson's disease; senile dementia; psychoses etc.
10/02/2008US20080242672 Adenosine a2a receptor antagonists
10/02/2008US20080242668 Neurodegenerative, inflammatory disorders, pain, drug abuse; useful as diagnostic tools or monitoring agents such as for neuroimaging, labelling; nicotinic and/or monoamine receptors modulators; 2,2'-Bis-((+-)-1-aza-bicyclo[2.2.2]oct-3-yloxy)-[5,5']-bithiazolyl; cholinergic ligands
10/02/2008US20080242661 Novel compounds useful for the treatment of degenerative & inflammatory diseases
10/02/2008US20080242658 Inhibitors of Iap
1 ... 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 ... 573